Introduction
APCL, a homologue of the adenomatous polyposis coli (APC) tumor suppressor gene Kinzler et al., 1991) , is expressed highly and speci®cally in the central nervous system (Nakagawa et al., 1998) . This pattern suggests that APCL has a more important role in proliferation and/or dierentiation of neuronal cells (Bhat et al., 1994) than APC, but its actual function remains unclear. As the heptad ± repeat domain of APC (Joslyn et al., 1993) is well conserved in APCL (45% identity), the latter protein is also likely to form homo-or hetero-dimers. Moreover, conservation also of the armadillo domain (Peifer et al., 1994) between APC and APCL (76% identity) suggests that both proteins interact with the same or similar molecules. The middle portion of APCL consists of ®ve copies of a 20-amino-acid motif (FXVEX-TPXCFSRXSSLSSLS) through which APCL can interact with beta-catenin and deplete intracellular beta-catenin, as APC does (Su et al., 1993; Minematsu et al., 1995) . However, its carboxyl terminus bears only 13% identity in sequence to the carboxyl region of APC protein that is thought to be involved in cell cycle progression (Baeg et al., 1995) or growth control (Morin et al., 1996) through binding to EB1 (Su et al., 1995) , microtubules (Smith et al., 1994) , and hDLG (Matsumine et al., 1996) . To shed light on the functions of APCL, we have been using a yeast twohybrid system to search for proteins that associate with its carboxyl region. These experiments revealed binding of this domain to a molecule related to EB1 (Su et al., 1995) . EB1 is known to be associated with the microtubule cytoskeleton of the mitotic spindle, where it is important for spindle assembly throughout the cell cycle (Berrueta et al., 1998; Morrison et al., 1998) . This novel member of the EB1 family, designated EB3, is expressed preferentially in the central nervous system, and we have demonstrated that like EB1, it can be associated with the microtubule cytoskeleton.
Results

Identi®cation of a novel EB1 homologue
To isolate human proteins that might interact with the carboxy-terminus of APCL protein, we screened a human fetal-brain cDNA library constructed with a GAL4 activator ± domain vector by the yeast twohybrid method. The bait was a construct containing the GAL4-binding domain fused to a 2.6 kb NotI fragment (nucleotides 4561 ± 7132) of APCL, a region with only 13% identity to the C-terminus of the APC protein. By screening 3.0610 7 yeast transformants, we isolated 166 cDNA clones as candidates for molecular interaction with APCL, and sequenced them. Among the 166 candidates, six were overlapping clones that contained parts of a novel gene which, when assembled, encoded a 282-amino-acid peptide ( Figure  1 ) with 54% identity to EB1, a molecule known to bind to APC. Two of the clones contained coding sequences identical to parts of EB1 itself, and the novel cDNAs were termed EB3. Northern blot analyses showed that an EB3 transcript of about 2.2 kb was expressed predominantly in brain and muscle, although EB1 was expressed ubiquitously (Figure 2 ). Using two BAC clones (222G8 and 362N23) containing EB3 sequence, we mapped this novel gene to chromosome 2p23.1 ± p23.3 by FISH analysis (Figure 3 ).
In-vitro binding of EB3 and EB1 to APCL
To con®rm the interactions indicated by the yeast two-hybrid system, we constructed plasmid clones designed to express GST-fused full-length EB1 and Figure 1 Alignment of the amino-acid sequences of EB3 and EB1. Identical residues are black (54% identical) Figure 2 Expression of EB3 in adult human tissues on Northern blots. EB3 is expressed preferentially in the central nervous system and muscle, but EB1 is expressed ubiquitously EB3, a novel member of EB1, binds to an APC homologue H Nakagawa et al EB3, and performed pull-down assays. An in vitrotranslated, 35 S-labeled carboxy-terminal fragment of APCL protein (codon 1374-stop) was tested for binding to GST alone, or to GST ± EB3 or GST ± EB1 coupled to glutathione-agarose beads. These experiments con®rmed that the C-terminal region of APCL protein was able to associate speci®cally with both GST ± EB3 and GST ± EB1 (Figure 4) .
Identi®cation of the EB-binding domain (EBBD) of APCL protein
After comparing the alignments of the C-terminal regions of APC and APCL, we selected four small S-labeled carboxyl termini of EB3 and EB1 were tested for binding to glutathione-agarose beads coupled with GST alone, GST ± EBBD1, GST ± EBBD2, GST ± EBBD3, or GST ± EBBD4. Both EB3 and EB1 were speci®cally associated with GST ± EBBD3 (green), but not with GST alone or other EBBD candidates Figure 3 Chromosomal location of EB3. The G-band pattern of the metaphase chromosomes indicates that both BAC clones containing EB3 sequence (222G8 and 362N23) hybridize only to 2p23.1 ± p23.3 Figure 4 In vitro binding of APCL with EB1 and EB3. GST ± EB1, GST ± EB3 , and GST alone were tested by GST pull-down assay. The C-terminal region of APCL protein associates with GST ± EB1 and GST-EB3, but not with GST alone EB3, a novel member of EB1, binds to an APC homologue H Nakagawa et al regions of identity (EBBD-1, 2, 3, 4) as candidate domains where APCL protein might bind directly to EB3 ( Figure 5a ). Their respective GST-fusion proteins were produced for GST pull-down assays. We synthesized 35 S-labeled, full-length EB3 and EB1 and tested each of them for binding to GST alone or to four kinds of GST ± EBBD fusion proteins. Only EBBD3 was able to bind in vitro-translated EB3 and EB1 (Figure 5b ).
In-vivo interaction of EB3 and APCL by co-immunoprecipitation
To characterize the interaction of EB3 and APCL in vivo, we investigated whether the two proteins would co-precipitate when epitope-tagged molecules were transiently expressed in mammalian cells. Western blotting of lysates of co-transfected cells detected FLAG-tagged EB3 as a *45 kDa protein and EB3, a novel member of EB1, binds to an APC homologue H Nakagawa et al APCL ± Myc as a *250 kDa protein. This result suggested that cells designed to express both APCL ± Myc and FLAG ± EB3 were enriched for these proteins. When we precipitated APCL ± Myc using anti-Myc antibody, we found that FLAG ± EB3 precipitated along with it ( Figure 6a) ; similarly, APCL ± Myc co-precipitated with FLAG ± EB3 when we used anti-FLAG antibody (Figure 6b ).
Sub-cellular localization of EB3
Cos-7 and SW480 cells were co-transfected with expression plasmids encoding FLAG-tagged EB3 and/ or Myc-tagged APCL. Confocal microscopy revealed that exogenous EB3 protein was present in the cytoplasmic microtubule network as well as endogenous EB1 protein (Berrueta et al., 1998; Morrison et al., 1998) . Myc-tagged full-length APCL was located mainly in the perinuclear region and partially in the cytoplasmic microtubule network; EB3 and APCL were co-localized in the perinucleus and the cytoplasmic microtubule network (Figure 7 ). To disrupt microtubule dynamics, we treated Cos-7 cells transfected with EB3 and/or APCL with 10 mM nocodazole for 45 min. The normal intracellular distribution of EB3 (Figure 8a ) was completely changed by the drug, and the staining pattern associated with the microtubule network was completely abolished (Figure 8b) . Furthermore, when microtubules were repolymerized by removal of nocodazole and incubation in normal medium for 10 min, the microtubule-associated staining pattern was completely recovered (Figure 8c ). These ®ndings con®rmed that EB3 was associated with microtubules. The distribution of APCL, however, was unchanged in the presence of nocodazole.
Discussion
The N-terminal and middle regions of APC and a brain-speci®c homologue, APCL, possess a high degree of homology (Nakagawa et al., 1998) . APCL interacts with beta-catenin through ®ve copies of a 20-aminoacid motif and, like APC, can deplete the intracellular beta-catenin pool (Nakagawa et al., 1998) . However, the respective carboxyl regions show little conservation. Furthermore, although APC is expressed ubiquitously , APCL is expressed speci®cally in the central nervous system; therefore, its C-terminal portion is likely to account for CNS-speci®c functions. To shed light on functions unique to APCL, we applied a yeast two-hybrid screening system to search for proteins that would interact speci®cally with the carboxyl region of APCL. This procedure unexpectedly identi®ed EB1, a molecule that had been isolated earlier by virtue of interaction with the carboxyterminal region of APC (Su et al., 1995) , as well as a novel homologue which we designated EB3. EB1 is known to be associated with the microtubule cytoskeleton of the mitotic spindle, where it is important for spindle assembly throughout the cell cycle (Berrueta et al., 1998; Morrison et al., 1998) . Furthermore, several yeast homologues of EB1 play important roles in regulating the integrity of microtubules (Beinhauser et al., 1997) , and some contribute to the sensor mechanism that activates the cytokinesis checkpoint (Muhua et al., 1998) . EB2 was identi®ed as an EB1 homologue by EST database search (Su et al., 1995) , but its function is still unknown. We con®rmed interaction between APCL and the novel EB1 homologue reported here (EB3), both in vitro and also in transiently overexpressing mammalian cells. Although the condition was arti®cial, we were unable to observe the APCL ± EB1 interaction by the same in vivo condition.
Northern blot analysis showed that like APCL, EB3 is expressed predominantly in the central nervous system; EB1 and APC, on the other hand, are both ubiquitously expressed. We speculated the EB-binding domain (EBBD) of APCL protein by comparing amino acid sequences of APC and APCL, and performing in vitro binding assays. The EBBD can interact directly with EB3 or EB1, and it shows no signi®cant similarity to any known proteins or motifs. In this small region, eight amino acids (SESPSRLP) are completely conserved between APC and APCL protein; this characteristic motif of the APC family might be essential for interaction with molecules of the EB family. Furthermore this EBBD motif of APC (codon 2537 ± 2544) is located at the 3' side of almost all APC When transiently expressed in mammalian cells, epitope-tagged EB3 was located in the microtubule cytoskeleton, as is EB1 (Berrueta et al., 1998; Morrison et al., 1998) ; drug-induced perturbation of the microtubules revealed that EB3 structure might be dependent on microtubule structure. When both epitope-tagged EB3 and APCL were transiently expressed in the same mammalian cells, these proteins appeared together in the perinuclear region and to some degree in the microtubule network, though epitope-tagged protein might localize dierently due to the epitope tag itself or its overexpression. The distribution pattern of exogenous EB3 did not depend on the localization of APCL. In similar fashion, the cellular distribution of EB1 is unaected by the presence or absence of normal APC protein, and APC is not required for association of EB1 with microtubules (Berrueta et al., 1998 (Berrueta et al., , 1999 . The most common APC mutation found in colorectal cancers leads to a truncated product lacking the EB1-binding region; loss of EB1 binding may lead to misregulation of mitosis and may contribute to the initiation of carcinogenesis. However, the signi®cance of APC ± EB1 interaction is not fully understood. The importance of APCL ± EB3 interaction is similarly unclear, but its speci®city for the central nervous system could well be involved in stability and/or extension of microtubules during neuronal neuritogenesis. Our ®ndings suggest that members of the APC family can interact with the EB family through a small domain (EBBD) in their respective carboxyl regions, and support the notion that these molecular interactions may, by aecting the microtubule network, regulate cell division or cell growth.
Materials and methods
Yeast two-hybrid screening
A yeast two-hybrid screening system was used to isolate cDNAs encoding proteins that would interact with the carboxyl terminus of APCL protein. To generate a fusion protein containing a GAL4-binding domain, a 2.6 kb NotI fragment was excised from the assembled cDNA clone of APCL and ligated into a SmaI site of pAS2-1 (Clontech) after blunting. This fusion plasmid was con®rmed to be inframe by sequencing and was used as bait to screen an oligo dT-primed human fetal-brain cDNA library in pACT2 vector (Clontech), according to the manufacturer's instructions. Brie¯y, the plasmids were transformed into Y190 yeast cells and positive clones were selected on Trp-, Leu-, His-plates containing 25 mM 3-aminotriazole, then assayed for betagalactosidase activity by colony-lift ®lter assay. To con®rm the interaction, positive clones were co-transformed into yeast with either the bait vector or the original pAS2-1 vector.
Northern blot analysis
A multiple-tissue Northern blot (Clontech) was hybridized at 428C with 32 PdCTP-labeled full-length EB3 or EB1 cDNAs obtained from yeast two-hybrid screening. The blots were washed in 26SSC at room temperature, then twice for 20 min in 0.16SSC containing 0.1% SDS, at 508C. Membranes were exposed to X-ray ®lm for 4 days at 7808C.
Chromosomal localization by¯uorescence in situ hybridization (FISH) analysis
Human metaphase chromosomes were prepared by the thymidine synchronization/bromodeoxyuridine release technique for the delineation of G-banding patterns. Before hybridization, metaphase cells were stained with Hoechst 33258 and irradiated with UV light. Two human BAC clones (222G8 and 362N23) containing EB3 sequence, purchased from Research Genetics, were labeled with biotin-16-dUTP (Boehringer) by nick-translation and hybridized to the denatured metaphase chromosomes. Hybridization signals were detected with FITC-avidin (Boehringer). Precise localization of the signals was determined by visualization of the replicated G-bands.
Production of GST-fusion protein cDNA fragments of EB3 were excised by BamHI and XhoI digestion from the positive plasmids obtained during the yeast two-hybrid screening. These fragments were ligated inframe into pGEX5-2 (Pharmacia) and con®rmed by sequencing. Overnight cultures of XL1 Blue MRF', transformed with the plasmids encoding GST-fusion proteins, were diluted and cultured for 6 h at 308C in the presence of 0.1 mM IPTG. Harvested cells were lysed by sonication in PBS containing 1% Triton X-100 and the lysate were clari®ed by centrifugation. GST-fusion proteins were puri®ed on glutathione agarose beads in PBS containing 1% Triton X-100. An equal amount of each GST-fusion protein was used for in vitro binding assays based on CBB staining.
In vitro binding of APCL to EB1 and EB3
A TNT lysate of rabbit reticulocytes (Promega) generated the 35 SMet-labeled C-terminus protein of APCL from a template containing nucleotides 4120 ± 6912 (stop) of APCL sequence downstream of a T7 promoter, according to the manufacturer's instructions. Immobilized GST-fusion proteins were mixed with in vitro-translated APCL proteins in TNE buer (10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA) containing 0.1% Triton X-100 and 1 mM PMSF for 3 h at 48C, then washed extensively with TNE buer four times. The beads were boiled in sample buer, and the released proteins were separated on 8% SDS ± PAGE gels. After electrophoresis the gels were dried and exposed to X-ray ®lm overnight at 7808C.
EB-binding domain (EBBD) of APCL
By comparing the amino-acid sequences of APC and APCL, we identi®ed four candidates (Figure 5a ). Their respective GST-fusion proteins were produced for GST pull-down assays by inserting full-length EB1 and EB3 into pcDNA-3.1 (+) HisA vector (Invitrogen) in frame. Then, in TNT rabbit reticulocyte lysates (Promega) we generated 35 SMetlabeled EB1 or EB3, using a T7 promoter according to the manufacturer's instructions. The GST pull-down assay was performed in the same way as the tests for in vitro binding of APCL to EB1 and EB3 described above.
Transfection to mammalian cells and in vivo interaction
To make epitope-tagged APCL and EB3 for studies of expression in mammalian cells, full-length APCL cDNA was inserted into pcDNA3.1 (+) Myc-HisA vector (Invitrogen) and full-length EB3 was inserted into pFLAG-CMV vector (Eastman-Kodak). Each was con®rmed to be in-frame by EB3, a novel member of EB1, binds to an APC homologue H Nakagawa et al sequencing. Cos-7 cells were incubated on 10-cm plates and transfected with 4 mg pCMV-FLAG-EB3 and 4 mg pCDNA3.1-APCL-Myc by lipofection (Lipofectamine plus; Life Technologies Inc.). After 24 h, cells were harvested in lysis buer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 150 mM NaCl, 1% Triton-X, 0.1% SDS, 0.1% DOC and cocktails of protease inhibitors). Cells were lysed by centrifugation at 14 000 r.p.m. for 30 min, mixed with 5 mg mouse anti-FLAG antibody (Eastman Kodak) or 5 mg rabbit anti-Myc antibody (Medical & Biological Laboratories), and rotated overnight at 48C. Thereafter, a 20-ml aliquot of Protein G-Sepharose beads (Pharmacia) was added and the mixtures were rotated for 2 h at 48C. The beads were washed extensively with buer (10 mM Tris-HCl [pH 7.5], 1 mM EDTA, 150 mM NaCl, 1% Triton-X) and boiled in SDS sample buer for 5 min. The released proteins were separated on 12% or 4% SDS ± PAGE gels and detected by Western blotting.
Immuno¯uorescent staining and nocodazole treatment
Cos-7 and SW 480 cells were cultured on coverslips and transfected with 1 mg pCMV-FLAG-EB3 and 1 mg pCDNA3.1-APCL-Myc or pCDNA3.1-truncated-APCLMyc by lipofection (Lipofectamine Plus; Life Technologies). Cells were ®xed 24 h later with 100% cold methanol for 5 min. After blocking overnight in PBS containing 10% fetal bovine serum, cells were treated for 1 h with a mixture of rabbit anti-Myc antibody (1/100; Medical & Biological Laboratories) and mouse anti-FLAG antibody (1/100; Eastman Kodak) in PBS containing 10% fetal bovine serum. The coverslips were washed three times for 10 min in PBS, incubated for 1 h in PBS containing 10% fetal bovine serum, FITC-conjugated sheep anti-mouse antibody (1/100; Cappel), and rhodamine-conjugated goat anti-rabbit antibody (1/100; Cappel), then washed four times in PBS. Immunouorescence was detected by confocal microscopy (Zeiss LSM 410).
To disrupt microtubules, we added nocodazole (Sigma) in a ®nal concentration of 10 mM to suspensions of the above mammalian cell lines, and incubated the suspensions for 45 min at 378C. After the drug-treated cells were washed three times in warm PBS, they were incubated in medium without nocodazole for 10 min at 378C, ®xed by cold 100% methanol for 5 min, and processed for analysis of immunouorescence.
